Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,880 total articles
Nuwellis, Inc. announced its Q1 2026 financial results showing a 26% increase in net sales to $2.4 million and gross margin improvement to 70.1%. The company completed the acquisition of Rendiatech, enhancing its cardiorenal monitoring capabilities, secured new U.S. patents, and expanded commercial coverage. These developments mark progress in its …
JE Cleantech Holdings Ltd, a Singapore-based cleantech and precision cleaning equipment manufacturer listed on NASDAQ, announced improved financial performance for the fiscal year ended December 31, 2025. The company posted revenue of S$20.3 million, a net income increase to S$3.2 million from S$0.03 million in the prior year, and adjusted EBITDA d…
Corbus Pharmaceuticals announced Q1 2026 financial results with a net loss of $23 million, alongside significant clinical progress. The company reached broad FDA alignment on CRB-701 registration for second-line head and neck and cervical cancers and completed patient enrollment in the obesity treatment study for CRB-913, with topline data expected…
SPAR Group, Inc. reported first quarter fiscal 2026 results showing a 10% year-over-year revenue decline primarily due to reduced US Remodel business, but achieved higher gross margins at 22.3% and returned to positive EBITDA. The company strategically shifted its focus toward higher-margin recurring merchandising revenue, resulting in U.S. Merchan…
Apollo-managed funds have acquired a majority interest in Noble Environmental, a vertically integrated waste management company operating in the Northeast, Mid-Atlantic, and Midwest United States. The acquisition emphasizes Apollo's commitment to investing in essential service businesses with long-life hard assets and growth potential, including No…
SunPower Inc. reported preliminary unaudited Q1 2026 results with revenue of $72.8 million, a 9% decline from Q4 2025, and a non-GAAP operating loss of $12.9 million due to revenue shortfall and increased spending in anticipation of Q3 growth. The company completed its 2025 10K audit with required restatements of prior quarterly reports due to acco…
Rhythm Pharmaceuticals announced new data presentations highlighting the efficacy of its drug setmelanotide in treating acquired hypothalamic obesity (HO) and Bardet-Biedl syndrome (BBS). Real-world data from France demonstrated significant and sustained BMI reductions in adults with acquired HO over 12 months. Phase 3 analyses showed improvements …
Genius Group Limited (NYSE American: GNS), a leader in AI-powered education, announced strong Q1 2026 financial results with 171% revenue growth year-over-year, and detailed its strategic entry into regulated digital banking via a 9.9% equity stake in Jewel Bank, Bermuda's uniquely dual-licensed digital bank. The company plans to leverage this inve…
Humacyte, Inc., a Nasdaq-listed biotech company specializing in bioengineered human tissues, announced the appointment of Dr. Todd E. Rasmussen, a distinguished vascular surgeon, as Chief Surgical Officer. Dr. Rasmussen brings extensive clinical expertise and leadership to support the clinical use and adoption of Humacyte’s flagship product Symvess…
Daré Bioscience announced encouraging interim results from its ongoing Phase 3 clinical trial for Ovaprene®, a hormone-free, intravaginal monthly contraceptive. The Data Safety Monitoring Board recommended continuing the study without modification, confirming Ovaprene's safety profile and contraceptive efficacy consistent with company expectations.…
Rezolve Ai (NASDAQ: RZLV) announced a strategic global partnership with Tata Consultancy Services (TCS), a major IT services leader with $30bn+ revenue. Under the agreement, TCS will resell Rezolve's AI-powered commerce platform to its extensive enterprise client base, expanding Rezolve's global market reach and accelerating adoption of its AI-nati…
ABM Industries Incorporated, a leading provider of facility, engineering, and infrastructure solutions, announced it received the 2026 IABC Gold Quill Award of Excellence in recognition of its enterprise-wide brand transformation. The company has strategically repositioned itself from a commoditized service provider to a consultative partner delive…
Kalaris Therapeutics reported progress in its Phase 1b/2 clinical study of TH103 for neovascular age-related macular degeneration, with patient screening underway and new clinical material batches manufactured. Preliminary data is anticipated in the first half of 2027, and Phase 3 trials remain on track for year-end 2027 initiation. As of March 31,…
PMV Pharmaceuticals announced its first quarter 2026 financial results and key corporate updates, highlighting progress in the development of rezatapopt, a first-in-class p53 reactivator for TP53 Y220C mutated cancers. The company reported on-track enrollment in the registrational Phase 2 PYNNACLE study, upcoming NDA submission scheduled for early …
Eagle Bancorp, Inc., a prominent community bank holding company in the Washington, D.C. area, announced the appointment of Stephen Curley as president and CEO effective July 6, 2026. Curley brings over 25 years of banking experience and a strong track record in commercial banking, deposit growth, capital allocation, and risk management. The leaders…
Diana Shipping Inc., a public US-listed dry bulk shipping company, has launched www.CashforGenco.com to support its campaign to elect six independent directors to Genco Shipping & Trading's board. Diana owns approximately 14.7% of Genco and has made an all-cash acquisition offer of $23.50 per share, representing a 31% premium. Diana highlights alle…
ZenaTech announces the establishment of Phoenix Aero LLC in Lviv, Ukraine, as a manufacturing hub for AI-enabled counter-UAS and interceptor drones aimed at Gulf Cooperation Council defense customers. The initiative leverages cost-effective production and real-world testing to meet growing Middle Eastern demand for scalable, affordable defense dron…
MiNK Therapeutics announced clinical data demonstrating that its off-the-shelf, allogeneic iNKT cell therapy, agenT-797, triggers disease-appropriate immune responses without genetic modification. The same cell product activated pro-inflammatory responses in cancer patients and anti-inflammatory effects in ARDS patients from the same manufacturing …
Collegium Pharmaceutical has finalized its acquisition of AZSTARYS, an ADHD medication, from Corium Therapeutics for approximately $650 million. The acquisition expands Collegium's ADHD product portfolio, leveraging existing commercial infrastructure to accelerate growth. The company has raised its 2026 financial guidance, expecting product revenue…
Mereo BioPharma disclosed its first quarter 2026 financial results and corporate updates, emphasizing ongoing regulatory discussions regarding setrusumab's potential pediatric use, active partnership talks for alvelestat Phase 3 development, and advancement of vantictumab's Phase 2 trial. Despite not meeting primary endpoints in setrusumab Phase 3 …
TappAlpha has announced surpassing $500 million in assets under management, doubling within just four months. The company's Growth + Income ETF strategies, including TSPY and TDAQ, focus on combining growth exposure with a tax-efficient income overlay. This milestone reflects strong advisor and investor demand for strategies that generate income wi…
Xilio Therapeutics reported strong first-quarter 2026 financial and operational results. The company is on track to submit an IND for XTX501, a bispecific PD-1/masked IL-2 therapy, mid-2026, with Phase 1 trial initiation planned for the second half of 2026. It presented promising preclinical data for XTX601 targeting CLDN18.2 and advanced multi-spe…
BriaCell Therapeutics Corp. reports that over 230 patients have been enrolled in its pivotal Phase 3 Bria-ABC study testing Bria-IMT in combination with an immune checkpoint inhibitor for metastatic breast cancer. The study, which has FDA Fast Track designation, expects to report interim topline overall survival data in 2026, potentially supporting…
Harvard Bioscience announced its financial results for Q1 2026, achieving revenues of $20.8 million with a gross margin improvement to 59%. The company remains profitable on an adjusted EBITDA basis and is progressing on manufacturing consolidation to achieve cost efficiencies. Adoption of higher-margin new product innovations (NPI), such as the Me…
Aveanna Healthcare Holdings Inc. announced its participation and presentation at the William Blair 46th Annual Growth Stock Conference on June 2, 2026. The company will showcase its range of pediatric and adult healthcare services, highlighting its focus on providing high-quality, cost-effective care alternatives to prolonged hospitalization.
